You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
Gastroenterology
Keeping an Eye on Pediatric EoE
Global experts Prof. Arjan Bredenoord and Drs. Ikuo Hirano, Kathryn Peterson, and Evan Dellon discuss identification and assessment of pediatric EoE.
MD, PhD
Arjan Bredenoord +3 more
Learning objectives
Recognize the difficulty of identification and diagnosis of pediatric EoE due to non-specific symptoms
Understand the symptoms and clinical phenotypes that are particular to pediatric EoE patients
Learn how to use tools for multidimensional assessment (e.g., symptoms, endoscopy, histology)
Recognize the impact of delayed diagnosis on disease progression and QoL
Description
Join global experts Ikuo Hirano, MD, Kathryn Peterson, MD, PhD, Evan Dellon, MD, MPH, and Arjan Bredenoord, MD, PhD, as they discuss the importance of identifying the early signs and symptoms of EoE in pediatric populations.
ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.
For healthcare professionals in Algeria: Please read the additional Terms of Use.
Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.